[Immunization strategies for treating melanoma].
Malignant melanoma is a highly aggressive although immunogenic tumor which can be recognized and destroyed by the immune system. Therefore, immunotherapy has been represented an essential part of the therapeutic arsenal for decades. Besides non-specific immunotherapeutic approaches (whole tumor cell vaccine, cytokine therapy, toll-like receptor agonists), targeted immunotherapy has been made possible by the identification of tumor-associated antigens. Despite undisputable successes, the ultimate breakthrough has not yet been achieved. This overview deals with the fundamental aspects of antigen-specific immunotherapy and highlights future strategies to improve its clinical efficacy.
Schultz
E S
ES
Klinik für Dermatologie und Allergologie, Universitätsklinikum Giessen und Marburg GmbH, Deutschhausstrasse 9, 35037, Marburg, Deutschland. eschultz@med.uni-marburg.de
Schuler
G
G
D000951:Antigens, Neoplasm / Q000627:therapeutic use*; D006801:Humans; D007114:Immunization / Q000379:methods*; D008545:Melanoma / Q000276:immunology* / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy*
D000951:Antigens, Neoplasm